Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year [Yahoo! Finance]
SANUWAVE Health, Inc. (SNWV)
NASDAQ:AMEX Investor Relations:
sanuwave.com/snwv/corporate_overview?title_override=overview
Company Research
Source: Yahoo! Finance
EDEN PRAIRIE, Minn., April 16, 2026 (GLOBE NEWSWIRE) Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved directed energy systems used in advanced wound care, today announced that revenues for the first quarter of 2026 are expected to be in the range of $9.6 to $9.7 million, an increase of 3-4% over Q1 2025. This number is within the range of guidance given in the Company's Q4 2025 earnings release issued on March 26, 2026. “At the end of Q1 the Company saw several good-sized deals (all of which remain live) slide out of the quarter and this brought us in toward the lower end of our guidance range,” said CEO Morgan Frank. “Q1 has been a sort of reckoning in the wound care space as practitioners and customers came to terms with some significant changes in reimbursement for skin substitutes and allografts and this has caused many market participants and practitioners to pause or pull back from their activities in advanced wound care.
Show less
Read more
Impact Snapshot
Event Time:
SNWV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNWV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNWV alerts
High impacting SANUWAVE Health, Inc. news events
Weekly update
A roundup of the hottest topics
SNWV
News
- Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-YearGlobeNewswire
- Sanuwave Health (SNWV) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Sanuwave Health (SNWV) had its "buy" rating reaffirmed by Roth Mkm. They now have a $47.00 price target on the stock, down from $53.00.MarketBeat
- How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV) [Yahoo! Finance]Yahoo! Finance
- Sanuwave Health (SNWV) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d-)" to "hold (c-)".MarketBeat
SNWV
Earnings
- 3/26/26 - Miss
SNWV
Sec Filings
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- SNWV's page on the SEC website